Inventor · disambiguated record
Pei Gan
Also filed as: GAN PEI · GAN PEI PEI
5 granted patents·11 pending applications·4 citations·filing 2009–2025
65Inventor score
Top patents by PatentIndex Score
16 records- 0194US11673894B2Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitorsINCYTE CORP·Filed 2020·Granted Jun 13, 2023·4 cites·25 claims
- 0280US2023357255A1Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitorsINCYTE CORP·Filed 2023·Application pending·0 cites
- 0375US2025313567A1Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitorsINCYTE CORP·Filed 2025·Application pending·0 cites
- 0475US2024360140A1Fused pyrazine derivatives as a2a / a2b inhibitorsINCYTE CORP·Filed 2024·Application pending·0 cites
- 0574US12421254B2KRAS modulators and uses thereofQUANTA THERAPEUTICS INC·Filed 2024·Granted Sep 23, 2025·0 cites·17 claims
- 0672US2024343742A1Vinyl imidazole compounds as inhibitors of krasINCYTE CORP·Filed 2024·Application pending·0 cites
- 0769US2025188073A1Tricyclic compounds as inhibitors of krasINCYTE CORP·Filed 2024·Application pending·0 cites
- 0867US11999740B2Fused pyrazine derivatives as A2A / A2B inhibitorsINCYTE CORP·Filed 2021·Granted Jun 4, 2024·0 cites·36 claims
- 0961US11999752B2Vinyl imidazole compounds as inhibitors of KRASINCYTE CORP·Filed 2021·Granted Jun 4, 2024·0 cites·38 claims
- 1060US2024101557A1Fused tricyclic compounds as inhibitors of kras g12v mutantsINCYTE CORP·Filed 2023·Application pending·0 cites
- 1160US2019292188A1Imidazopyrimidines and triazolopyrimidines as a2a / a2b inhibitorsINCYTE CORP·Filed 2019·Application pending·0 cites
- 1258US2021269434A1Tricyclic compounds as inhibitors of krasINCYTE CORP·Filed 2021·Application pending·0 cites
- 1357US2023226040A1Combination therapy comprising an fgfr inhibitor and a kras inhibitorINCYTE CORP·Filed 2022·Application pending·0 cites
- 1456US12441727B2Tricyclic compounds as inhibitors of KRASINCYTE CORP·Filed 2022·Granted Oct 14, 2025·0 cites·31 claims
- 1548US2010159030A1Methods for detecting and modulating the sensitivity of tumor cells to anti-mitotic agents and for modulating turmorgenicityNEWSOUTH INNOVATIONS PTY LTD·Filed 2009·Application pending·0 cites
- 1631US2016175339A1Methods for detecting and modulating the sensitivity of tumor cells to anti-mitotic agents and for modulating tumorigenicityNEWSOUTH INNOVATIONS PTY LTD·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pei Gan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →